Rankings
▼
Calendar
KMDA Q1 2020 Earnings — Kamada Ltd. Revenue & Financial Results | Market Cap Arena
KMDA
Kamada Ltd.
$495M
Q1 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$33M
+24.2% YoY
Gross Profit
$11M
34.4% margin
Operating Income
$5M
14.6% margin
Net Income
$5M
15.7% margin
EPS (Diluted)
$0.12
QoQ Revenue Growth
+3.8%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$3M
Stock-Based Comp.
$257,000
Balance Sheet
Total Assets
$197M
Total Liabilities
$31M
Stockholders' Equity
$166M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$33M
$27M
+24.2%
Gross Profit
$11M
$11M
+2.4%
Operating Income
$5M
$5M
-6.9%
Net Income
$5M
$5M
+6.0%
← FY 2020
All Quarters
Q2 2020 →